(Q39690146)

English

Comparative effectiveness of ledipasvir/sofosbuvir ± ribavirin vs. ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in 6961 genotype 1 patients treated in routine medical practice.

scientific article published on 13 June 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27291852%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Comparative effectiveness of ledipasvir/sofosbuvir ± ribavirin vs. ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in 6961 genotype 1 patients treated in routine medical practice (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27291852%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27291852%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

P S Belperio

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27291852%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

T A Shahoumian

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27291852%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

T P Loomis

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27291852%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

L A Mole

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27291852%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

language of work or name

0 references

publication date

13 June 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27291852%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27291852%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

44

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27291852%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27291852%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

400-410

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27291852%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

Editorial Commentary: Interferon-free Hepatitis C Treatment Efficacy From Clinical Trials Will Translate to "Real World" Outcomes

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

Early View of the Effectiveness of New Direct-Acting Antiviral (DAA) Regimens in Patients with Hepatitis C Virus (HCV)

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

Effectiveness of sofosbuvir-based regimens in genotype 1 and 2 hepatitis C virus infection in 4026 U.S. Veterans.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

Treatment of chronic HCV with sofosbuvir and simeprevir in patients with cirrhosis and contraindications to interferon and/or ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype 1b infection.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

Hepatitis C virus screening and prevalence among US veterans in Department of Veterans Affairs care

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

Clinical Case Registries: simultaneous local and national disease registries for population quality management

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

Real-world effectiveness of ledipasvir/sofosbuvir in 4,365 treatment-naive, genotype 1 hepatitis C-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

Similar effectiveness of boceprevir and telaprevir treatment regimens for hepatitis C virus infection on the basis of a nationwide study of veterans

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13696

21 January 2018

Identifiers

10.1111/APT.13696

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27291852%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27291852%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39690146&oldid=1475690000"